Oxytetracycline + Flunixin Meglumine Injection

Short Description:

This product is mainly indicated for treatment of bovine respiratory disease associated with Mannheimia haemolytica,where an anti-inflammatory and anti- pyretic effect is required. In addition a wide range of organisms including Pasteurellaspp, Arcanobacterium pyogenes, Staphylococcus aureus and certain mycoplasmas are known to be sensitive in vitro to oxytetracycline.


  • Price: FOB Shanghai: Discuss in Person
  • MOQ(50ml,100ml(g)): 5000 Bottle/Bag
  • MOQ(250ml,500ml(g)): 2000 Bottle/Bag
  • MOQ(5ml,10ml): 30000 Bottle/Vial
  • Shipment Port: Shanghai, Guangzhou, Chongqing, Yiwu
  • Payment Terms: T/T, L/C
  • Product Detail

    Send Message

    Composition
    Each ml contains:
    Oxytetracycline……….…300mg
    Flunixin meglumine…….20mg

    Indication
    This injection is indicated primarily for the treatment of bovine respiratory disease associated with Mannheimia haemolytica,where an anti-inflammatory and anti- pyretic effect is required. In addition a wide range of organisms including Pasteurellaspp, Arcanobacterium pyogenes, Staphylococcus aureus and certain mycoplasmas are known to be sensitive in vitro to oxytetracycline.

    Dosage and Administration
    For deep intramuscular injection to cattle.
    The recommended dosage is 1ml per 10kg bodyweight (equivalent to 30mg/kg oxytetracycline and 2mg/kg flunixin meglumine) on a single occasion.
    Maximum volume per injection site: 15ml. If concurrent treatment is administered, use a separate injection site.

    Side Effects
    Use is contraindicated in animals suffering from cardiac, hepatic or renal disease, where there is a possibility of gastrointestinal ulceration or bleeding or where there is hyper sensitivity to the product.
    Avoid use in dehydrated, hypovolaemic or hypotensive animals as there is a potential risk of increased renal toxicity.
    Do not administer other NSAIDs concurrently or within 24hours of each other.
    Concurrent use of potentially nephrotoxic drugs should beavoided. Do not exceed the stated dose or duration of treatment.

    Withdrawal Time
    Animals must not be slaughtered for human consumption during treatment.
    Cattle may be slaughtered for human consumption only after 35 days from the last treatment.
    Not for use in cattle producing milk for human consumption.

    Storage and Expired Time
    Tightly sealed and store below 25℃, avoid direct sun lights.
    2 years.

    Packing
    10ml, 50ml, 100ml

    Concentration
    30%+2.0%, 20%+5.0%